The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Platelet Rich Plasma (PRP) Market Research Report 2024
Synopsis
Platelet Rich Plasma is a biologic isolated from whole blood that is preferentially enriched for platelets. While platelets are the primary component of PRP, preparations may also contain other cellular components such as white blood cells (WBCs) and peripheral stem cells. These components all play a biological role in the healing process and are provided at concentrated levels in PRP. Thus, PRP may help optimize the conditions for healing of bone and soft tissue.
The global Platelet Rich Plasma (PRP) market was valued at US$ 295 million in 2023 and is anticipated to reach US$ 625.5 million by 2030, witnessing a CAGR of 11.2% during the forecast period 2024-2030.
Global Platelet Rich Plasma key players include Harvest Technologies, DePuy Synthes, Stryker, Zimmer Biomet, etc. Global top four manufacturers hold a share about 75%.
North America is the largest market, with a share about 55%, followed by Asia-Pacific and Europe, both have a share over 40 percent.
In terms of product, P-PRP is the largest segment, with a share over 60%. And in terms of application, the largest application is Orthopedic Surgery, followed by Cosmetic Surgery, General Surgery, etc.
This report aims to provide a comprehensive presentation of the global market for Platelet Rich Plasma (PRP), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Platelet Rich Plasma (PRP).
Report Scope
The Platelet Rich Plasma (PRP) market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Platelet Rich Plasma (PRP) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Platelet Rich Plasma (PRP) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Harvest Technologies
DePuy Synthes
Stryker
Zimmer Biomet
Arthrex
Exactech
Emcyte Corporation
Arteriocyte
Adilyfe
Segment by Type
P-PRP
L-PRP
L-PRF
Segment by Application
Orthopedic Surgery
Cosmetic Surgery
General Surgery
Other Surgeries
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Platelet Rich Plasma (PRP) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Platelet Rich Plasma (PRP) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Platelet Rich Plasma is a biologic isolated from whole blood that is preferentially enriched for platelets. While platelets are the primary component of PRP, preparations may also contain other cellular components such as white blood cells (WBCs) and peripheral stem cells. These components all play a biological role in the healing process and are provided at concentrated levels in PRP. Thus, PRP may help optimize the conditions for healing of bone and soft tissue.
The global Platelet Rich Plasma (PRP) market was valued at US$ 295 million in 2023 and is anticipated to reach US$ 625.5 million by 2030, witnessing a CAGR of 11.2% during the forecast period 2024-2030.
Global Platelet Rich Plasma key players include Harvest Technologies, DePuy Synthes, Stryker, Zimmer Biomet, etc. Global top four manufacturers hold a share about 75%.
North America is the largest market, with a share about 55%, followed by Asia-Pacific and Europe, both have a share over 40 percent.
In terms of product, P-PRP is the largest segment, with a share over 60%. And in terms of application, the largest application is Orthopedic Surgery, followed by Cosmetic Surgery, General Surgery, etc.
This report aims to provide a comprehensive presentation of the global market for Platelet Rich Plasma (PRP), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Platelet Rich Plasma (PRP).
Report Scope
The Platelet Rich Plasma (PRP) market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Platelet Rich Plasma (PRP) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Platelet Rich Plasma (PRP) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Harvest Technologies
DePuy Synthes
Stryker
Zimmer Biomet
Arthrex
Exactech
Emcyte Corporation
Arteriocyte
Adilyfe
Segment by Type
P-PRP
L-PRP
L-PRF
Segment by Application
Orthopedic Surgery
Cosmetic Surgery
General Surgery
Other Surgeries
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Platelet Rich Plasma (PRP) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Platelet Rich Plasma (PRP) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Platelet Rich Plasma (PRP) Market Overview
1.1 Product Overview and Scope of Platelet Rich Plasma (PRP)
1.2 Platelet Rich Plasma (PRP) Segment by Type
1.2.1 Global Platelet Rich Plasma (PRP) Market Value Comparison by Type (2024-2030)
1.2.2 P-PRP
1.2.3 L-PRP
1.2.4 L-PRF
1.3 Platelet Rich Plasma (PRP) Segment by Application
1.3.1 Global Platelet Rich Plasma (PRP) Market Value by Application: (2024-2030)
1.3.2 Orthopedic Surgery
1.3.3 Cosmetic Surgery
1.3.4 General Surgery
1.3.5 Other Surgeries
1.4 Global Platelet Rich Plasma (PRP) Market Size Estimates and Forecasts
1.4.1 Global Platelet Rich Plasma (PRP) Revenue 2019-2030
1.4.2 Global Platelet Rich Plasma (PRP) Sales 2019-2030
1.4.3 Global Platelet Rich Plasma (PRP) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Platelet Rich Plasma (PRP) Market Competition by Manufacturers
2.1 Global Platelet Rich Plasma (PRP) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Platelet Rich Plasma (PRP) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Platelet Rich Plasma (PRP) Average Price by Manufacturers (2019-2024)
2.4 Global Platelet Rich Plasma (PRP) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Platelet Rich Plasma (PRP), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Platelet Rich Plasma (PRP), Product Type & Application
2.7 Platelet Rich Plasma (PRP) Market Competitive Situation and Trends
2.7.1 Platelet Rich Plasma (PRP) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Platelet Rich Plasma (PRP) Players Market Share by Revenue
2.7.3 Global Platelet Rich Plasma (PRP) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Platelet Rich Plasma (PRP) Retrospective Market Scenario by Region
3.1 Global Platelet Rich Plasma (PRP) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Platelet Rich Plasma (PRP) Global Platelet Rich Plasma (PRP) Sales by Region: 2019-2030
3.2.1 Global Platelet Rich Plasma (PRP) Sales by Region: 2019-2024
3.2.2 Global Platelet Rich Plasma (PRP) Sales by Region: 2025-2030
3.3 Global Platelet Rich Plasma (PRP) Global Platelet Rich Plasma (PRP) Revenue by Region: 2019-2030
3.3.1 Global Platelet Rich Plasma (PRP) Revenue by Region: 2019-2024
3.3.2 Global Platelet Rich Plasma (PRP) Revenue by Region: 2025-2030
3.4 North America Platelet Rich Plasma (PRP) Market Facts & Figures by Country
3.4.1 North America Platelet Rich Plasma (PRP) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Platelet Rich Plasma (PRP) Sales by Country (2019-2030)
3.4.3 North America Platelet Rich Plasma (PRP) Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Platelet Rich Plasma (PRP) Market Facts & Figures by Country
3.5.1 Europe Platelet Rich Plasma (PRP) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Platelet Rich Plasma (PRP) Sales by Country (2019-2030)
3.5.3 Europe Platelet Rich Plasma (PRP) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Platelet Rich Plasma (PRP) Market Facts & Figures by Country
3.6.1 Asia Pacific Platelet Rich Plasma (PRP) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Platelet Rich Plasma (PRP) Sales by Country (2019-2030)
3.6.3 Asia Pacific Platelet Rich Plasma (PRP) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Platelet Rich Plasma (PRP) Market Facts & Figures by Country
3.7.1 Latin America Platelet Rich Plasma (PRP) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Platelet Rich Plasma (PRP) Sales by Country (2019-2030)
3.7.3 Latin America Platelet Rich Plasma (PRP) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Platelet Rich Plasma (PRP) Market Facts & Figures by Country
3.8.1 Middle East and Africa Platelet Rich Plasma (PRP) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Platelet Rich Plasma (PRP) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Platelet Rich Plasma (PRP) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Platelet Rich Plasma (PRP) Sales by Type (2019-2030)
4.1.1 Global Platelet Rich Plasma (PRP) Sales by Type (2019-2024)
4.1.2 Global Platelet Rich Plasma (PRP) Sales by Type (2025-2030)
4.1.3 Global Platelet Rich Plasma (PRP) Sales Market Share by Type (2019-2030)
4.2 Global Platelet Rich Plasma (PRP) Revenue by Type (2019-2030)
4.2.1 Global Platelet Rich Plasma (PRP) Revenue by Type (2019-2024)
4.2.2 Global Platelet Rich Plasma (PRP) Revenue by Type (2025-2030)
4.2.3 Global Platelet Rich Plasma (PRP) Revenue Market Share by Type (2019-2030)
4.3 Global Platelet Rich Plasma (PRP) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Platelet Rich Plasma (PRP) Sales by Application (2019-2030)
5.1.1 Global Platelet Rich Plasma (PRP) Sales by Application (2019-2024)
5.1.2 Global Platelet Rich Plasma (PRP) Sales by Application (2025-2030)
5.1.3 Global Platelet Rich Plasma (PRP) Sales Market Share by Application (2019-2030)
5.2 Global Platelet Rich Plasma (PRP) Revenue by Application (2019-2030)
5.2.1 Global Platelet Rich Plasma (PRP) Revenue by Application (2019-2024)
5.2.2 Global Platelet Rich Plasma (PRP) Revenue by Application (2025-2030)
5.2.3 Global Platelet Rich Plasma (PRP) Revenue Market Share by Application (2019-2030)
5.3 Global Platelet Rich Plasma (PRP) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Harvest Technologies
6.1.1 Harvest Technologies Corporation Information
6.1.2 Harvest Technologies Description and Business Overview
6.1.3 Harvest Technologies Platelet Rich Plasma (PRP) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Harvest Technologies Platelet Rich Plasma (PRP) Product Portfolio
6.1.5 Harvest Technologies Recent Developments/Updates
6.2 DePuy Synthes
6.2.1 DePuy Synthes Corporation Information
6.2.2 DePuy Synthes Description and Business Overview
6.2.3 DePuy Synthes Platelet Rich Plasma (PRP) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 DePuy Synthes Platelet Rich Plasma (PRP) Product Portfolio
6.2.5 DePuy Synthes Recent Developments/Updates
6.3 Stryker
6.3.1 Stryker Corporation Information
6.3.2 Stryker Description and Business Overview
6.3.3 Stryker Platelet Rich Plasma (PRP) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Stryker Platelet Rich Plasma (PRP) Product Portfolio
6.3.5 Stryker Recent Developments/Updates
6.4 Zimmer Biomet
6.4.1 Zimmer Biomet Corporation Information
6.4.2 Zimmer Biomet Description and Business Overview
6.4.3 Zimmer Biomet Platelet Rich Plasma (PRP) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Zimmer Biomet Platelet Rich Plasma (PRP) Product Portfolio
6.4.5 Zimmer Biomet Recent Developments/Updates
6.5 Arthrex
6.5.1 Arthrex Corporation Information
6.5.2 Arthrex Description and Business Overview
6.5.3 Arthrex Platelet Rich Plasma (PRP) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Arthrex Platelet Rich Plasma (PRP) Product Portfolio
6.5.5 Arthrex Recent Developments/Updates
6.6 Exactech
6.6.1 Exactech Corporation Information
6.6.2 Exactech Description and Business Overview
6.6.3 Exactech Platelet Rich Plasma (PRP) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Exactech Platelet Rich Plasma (PRP) Product Portfolio
6.6.5 Exactech Recent Developments/Updates
6.7 Emcyte Corporation
6.6.1 Emcyte Corporation Corporation Information
6.6.2 Emcyte Corporation Description and Business Overview
6.6.3 Emcyte Corporation Platelet Rich Plasma (PRP) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Emcyte Corporation Platelet Rich Plasma (PRP) Product Portfolio
6.7.5 Emcyte Corporation Recent Developments/Updates
6.8 Arteriocyte
6.8.1 Arteriocyte Corporation Information
6.8.2 Arteriocyte Description and Business Overview
6.8.3 Arteriocyte Platelet Rich Plasma (PRP) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Arteriocyte Platelet Rich Plasma (PRP) Product Portfolio
6.8.5 Arteriocyte Recent Developments/Updates
6.9 Adilyfe
6.9.1 Adilyfe Corporation Information
6.9.2 Adilyfe Description and Business Overview
6.9.3 Adilyfe Platelet Rich Plasma (PRP) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Adilyfe Platelet Rich Plasma (PRP) Product Portfolio
6.9.5 Adilyfe Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Platelet Rich Plasma (PRP) Industry Chain Analysis
7.2 Platelet Rich Plasma (PRP) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Platelet Rich Plasma (PRP) Production Mode & Process
7.4 Platelet Rich Plasma (PRP) Sales and Marketing
7.4.1 Platelet Rich Plasma (PRP) Sales Channels
7.4.2 Platelet Rich Plasma (PRP) Distributors
7.5 Platelet Rich Plasma (PRP) Customers
8 Platelet Rich Plasma (PRP) Market Dynamics
8.1 Platelet Rich Plasma (PRP) Industry Trends
8.2 Platelet Rich Plasma (PRP) Market Drivers
8.3 Platelet Rich Plasma (PRP) Market Challenges
8.4 Platelet Rich Plasma (PRP) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
